Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans
Kun-Wei Liu, … , Bo Hu, Shi-Yuan Cheng
Kun-Wei Liu, … , Bo Hu, Shi-Yuan Cheng
Published February 14, 2011
Citation Information: J Clin Invest. 2011;121(3):905-917. https://doi.org/10.1172/JCI43690.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 3

SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans

  • Text
  • PDF
Abstract

Recent collaborative efforts have subclassified malignant glioblastomas into 4 clinical relevant subtypes based on their signature genetic lesions. Platelet-derived growth factor receptor α (PDGFRA) overexpression is concomitant with a loss of cyclin-dependent kinase inhibitor 2A (CDKN2A) locus (encoding P16INK4A and P14ARF) in a large number of tumors within one subtype of glioblastomas. Here we report that activation of PDGFRα conferred tumorigenicity to Ink4a/Arf-deficient mouse astrocytes and human glioma cells in the brain. Restoration of p16INK4a but not p19ARF suppressed PDGFRα-promoted glioma formation. Mechanistically, abrogation of signaling modules in PDGFRα that lost capacity to bind to SHP-2 or PI3K significantly diminished PDGFRα-promoted tumorigenesis. Furthermore, inhibition of SHP-2 by shRNAs or pharmacological inhibitors disrupted the interaction of PI3K with PDGFRα, suppressed downstream AKT/mTOR activation, and impaired tumorigenesis of Ink4a/Arf-null cells, whereas expression of an activated PI3K mutant rescued the effect of SHP-2 inhibition on tumorigenicity. PDGFRα and PDGF-A are co-expressed in clinical glioblastoma specimens, and such co-expression is linked with activation of SHP-2/AKT/mTOR signaling. Together, our data suggest that in glioblastomas with Ink4a/Arf deficiency, overexpressed PDGFRα promotes tumorigenesis through the PI3K/AKT/mTOR-mediated pathway regulated by SHP-2 activity. These findings functionally validate the genomic analysis of glioblastomas and identify SHP-2 as a potential target for treatment of glioblastomas.

Authors

Kun-Wei Liu, Haizhong Feng, Robert Bachoo, Andrius Kazlauskas, Erin M. Smith, Karen Symes, Ronald L. Hamilton, Motoo Nagane, Ryo Nishikawa, Bo Hu, Shi-Yuan Cheng

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 1 6 5 4 4 4 4 6 1 4 4 4 5 6 1 59
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (59)

Title and authors Publication Year
Multi-scale signaling and tumor evolution in high-grade gliomas.
Liu J, Cao S, Imbach KJ, Gritsenko MA, Lih TM, Kyle JE, Yaron-Barir TM, Binder ZA, Li Y, Strunilin I, Wang YT, Tsai CF, Ma W, Chen L, Clark NM, Shinkle A, Naser Al Deen N, Caravan W, Houston A, Simin FA, Wyczalkowski MA, Wang LB, Storrs E, Chen S, Illindala R, Li YD, Jayasinghe RG, Rykunov D, Cottingham SL, Chu RK, Weitz KK, Moore RJ, Sagendorf T, Petyuk VA, Nestor M, Bramer LM, Stratton KG, Schepmoes AA, Couvillion SP, Eder J, Kim YM, Gao Y, Fillmore TL, Zhao R, Monroe ME, Southard-Smith AN, Li YE, Jui-Hsien Lu R, Johnson JL, Wiznerowicz M, Hostetter G, Newton CJ, Ketchum KA, Thangudu RR, Barnholtz-Sloan JS, Wang P, Fenyö D, An E, Thiagarajan M, Robles AI, Mani DR, Smith RD, Porta-Pardo E, Cantley LC, Iavarone A, Chen F, Mesri M, Nasrallah MP, Zhang H, Resnick AC, Chheda MG, Rodland KD, Liu T, Ding L
Cancer cell 2024
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q, Yu B, Zhang Y, Yang Y, Xu C, Zhang M, Chen G, Luo F, Sun B, Yang R, Li Y, Feng H
Cellular oncology (Dordrecht) 2023
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade.
Donini C, Galvagno F, Rotolo R, Massa A, Merlini A, Scagliotti GV, Novello S, Bironzo P, Leuci V, Sangiolo D
British Journal of Cancer 2023
Long-term environmental metal exposure is associated with hypomethylation of CpG sites in NFKB1 and other genes related to oncogenesis.
Stepanyan A, Petrackova A, Hakobyan S, Savara J, Davitavyan S, Kriegova E, Arakelyan A
Clinical Epigenetics 2023
Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis.
Goenka A, Song X, Tiek D, Iglesia RP, Lu M, Zeng C, Horbinski C, Zhang W, Hu B, Cheng SY
Neuro-Oncology 2023
Tumor radiogenomics in gliomas with Bayesian layered variable selection
Mohammed S, Kurtek S, Bharath K, Rao A, Baladandayuthapani V
Medical image analysis 2023
Complex Roles of PTPN11/SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy
Scheiter A, Lu LC, Gao LH, Feng GS
Annual review of cancer biology 2023
Identification of novel proteins for lacunar stroke by integrating genome-wide association data and human brain proteomes
Zhang C, Qin F, Li X, Du X, Li T
BMC Medicine 2022
Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma
RALLIS KS, GEORGE AM, WOZNIAK AM, BIGOGNO CM, CHOW B, HANRAHAN JG, SIDERIS M
Cancer genomics & proteomics 2022
Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy
Tang X, Qi C, Zhou H, Liu Y
Frontiers in Oncology 2022
Probabilistic edge inference of gene networks with markov random field-based bayesian learning
Huang YJ, Mukherjee R, Hsiao CK
Frontiers in Genetics 2022
Current understanding of gliomagenesis: from model to mechanism
Luo J, Junaid M, Hamid N, Duan JJ, Yang X, Pei DS
International journal of medical sciences 2022
The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin
G Peng, Y Wang, P Ge, C Bailey, P Zhang, D Zhang, Z Meng, C Qi, Q Chen, J Chen, J Niu, P Zheng, Y Liu, Y Liu
Journal of Experimental & Clinical Cancer Research 2021
Non-canonical PD-1 signaling in cancer and its potential implications in clinic
H Zha, Y Jiang, , J Shang, N Wang, L Yu, W Zhao, Z Li, J An, X Zhang, H Chen, B Zhu, Z Li
Journal for ImmunoTherapy of Cancer 2021
Prenatal overexpression of platelet‐derived growth factor receptor A results in central nervous system hypomyelination
HJ Cardona, A Somasundaram, DM Crabtree, SL Gadd, OJ Becher
Brain and Behavior 2021
Rates and patterns of clonal oncogenic mutations in the normal human brain
Ganz J, Maury EA, Becerra B, Bizzotto S, Doan RN, Kenny CJ, Shin T, Kim J, Zhou Z, Ligon KL, Alice Lee E, Walsh CA
Cancer Discovery 2021
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
W Yu, Y Hua, H Qiu, J Hao, K Zou, Z Li, S Hu, P Guo, M Chen, S Sui, Y Xiong, F Li, J Lu, W Guo, G Luo, W Deng
Cell Death and Disease 2020
Pediatric low-grade glioma in the era of molecular diagnostics
S Ryall, U Tabori, C Hawkins
Acta Neuropathologica Communications 2020
SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer
L Zhang, C Yuan, J Peng, L Zhou, Y Jiang, Y Lin, W Yin, S Xu, J Ma, J Lu
Frontiers in Oncology 2020
Genetic characterization of an aggressive optic nerve pilocytic glioma
CS Hong, G Fliney, A Fisayo, Y An, PP Gopal, A Omuro, R Pointdujour-Lim, EZ Erson-Omay, SB Omay
Brain Tumor Pathology 2020
Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response
Y Wang, Y Hou, W Zhang, AA Alvarez, Y Bai, B Hu, SY Cheng, K Yang, Y Li, H Feng
Journal of Experimental & Clinical Cancer Research 2019
Rare Pediatric Invasive Gliofibroma Has BRAF V600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution
K Kaneva, KK Yeo, D Hawes, J Ji, JA Biegel, MD Nelson, S Bluml, MD Krieger, A Erdreich-Epstein
JCO Precision Oncology 2019
An allosteric inhibitor of SHP2 effectively targets PDGFRα-driven glioblastoma
BA Tannous, CE Badr
Neuro-Oncology 2019
Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2–mediated signaling
Y Sang, Y Hou, R Cheng, L Zheng, AA Alvarez, B Hu, SY Cheng, W Zhang, Y Li, H Feng
Neuro-Oncology 2019
Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells
J Wang, P Sun, Y Chen, H Yao, S Wang
Scientific Reports 2018
SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
M Zhao, W Guo, Y Wu, C Yang, L Zhong, G Deng, Y Zhu, W Liu, Y Gu, Y Lu, L Kong, X Meng, Q Xu, Y Sun
Acta pharmaceutica Sinica. B 2018
Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells
AW Hall, AM Battenhouse, H Shivram, AR Morris, MC Cowperthwaite, M Shpak, VR Iyer
Cancer research 2018
piRNA-8041 is downregulated in human glioblastoma and suppresses tumor growth in vitro and in vivo
DI Jacobs, Q Qin, A Fu, Z Chen, J Zhou, Y Zhu
Oncotarget 2018
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
D Lv, Y Li, W Zhang, AA Alvarez, L Song, J Tang, WQ Gao, B Hu, SY Cheng, H Feng
Nature Communications 2017
T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice
W Liu, W Guo, L Shen, Z Chen, Q Luo, X Luo, GS Feng, Y Shu, Y Gu, Q Xu, Y Sun
Oncotarget 2017
EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines
D Chakravarty, AM Pedraza, J Cotari, AH Liu, D Punko, A Kokroo, JT Huse, G Altan-Bonnet, CW Brennan
Scientific Reports 2017
SHP2 regulates proliferation and tumorigenicity of glioma stem cells
L Roccograndi, ZA Binder, L Zhang, N Aceto, Z Zhang, M Bentires-Alj, I Nakano, N Dahmane, DM ORourke
Journal of Neuro-Oncology 2017
PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway
J Singh, K Sharma, PP Pillai
Cytotechnology 2017
Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding
D Lv, F Jia, Y Hou, Y Sang, AA Alvarez, W Zhang, WQ Gao, B Hu, SY Cheng, J Ge, Y Li, H Feng
Cancer research 2017
SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans
L Zhang, W Zhang, Y Li, A Alvarez, Z Li, Y Wang, L Song, D Lv, I Nakano, B Hu, SY Cheng, H Feng
Oncogene 2016
Pediatric gliomas as neurodevelopmental disorders: Developmental Biology of Childhood Gliomas
SJ Baker, DW Ellison, DH Gutmann
Glia 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
S Kleffel, C Posch, SR Barthel, H Mueller, C Schlapbach, E Guenova, CP Elco, N Lee, VR Juneja, Q Zhan, CG Lian, R Thomi, W Hoetzenecker, A Cozzio, R Dummer, MC Mihm, KT Flaherty, MH Frank, GF Murphy, AH Sharpe, TS Kupper, T Schatton
Cell 2015
Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
S Bunda, K Burrell, P Heir, L Zeng, A Alamsahebpour, Y Kano, B Raught, ZY Zhang, G Zadeh, M Ohh
Nature Communications 2015
Cell of Origin for Malignant Gliomas and Its Implication in Therapeutic Development
H Zong, LF Parada, SJ Baker
Cold Spring Harbor perspectives in biology 2015
EGFR Phosphorylation of DCBLD2 Recruits TRAF6 and Stimulates Akt-promoted Tumorigenesis
Haizhong Feng, Giselle Lopez, Chung Kwon Kim, Angel Alvarez, Christopher Duncan, Ryo Nishikawa, Motoo Nagane, An-jey Su, Philip Auron, Matthew Hedberg, Lin Wang, Jeffrey Raizer, John A. Kessler, Andrew Parsa, Wei-Qiang Gao, Sung-Hak Kim, Mutsuko Minanta, Ichiro Nakano, Jennifer R. Grandis, Roger McLendon, Darell Bigner, Hui-Kuan Lin, Frank Furnari, Webster K. Cavenee, Bo Hu, Hai Yan, Shi-Yuan Cheng
Journal of Clinical Investigation 2014
The Genetic Signatures of Pediatric High-Grade Glioma: No Longer a One-Act Play
AK Diaz, SJ Baker
Seminars in radiation oncology 2014
MicroRNA Profiling Reveals Unique miRNA Signatures in IGF-1 Treated Embryonic Striatal Stem Cell Fate Decisions in Striatal Neurogenesis In Vitro
S Pati, NE Supeno, S Muthuraju, RA Hadi, AR Ghani, FM Idris, M Maletic-Savatic, JM Abdullah, H Jaafar
BioMed Research International 2014
Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived growth factor receptor  
H Feng, Y Li, Y Yin, W Zhang, Y Hou, L Zhang, Z Li, B Xie, WQ Gao, JN Sarkaria, JJ Raizer, CD James, AT Parsa, B Hu, SY Cheng
Neuro-Oncology 2014
Targeting the PDGF signaling pathway in tumor treatment
CH Heldin
Cell Communication and Signaling 2013
A Reactive Oxygen Species-Mediated, Self-Perpetuating Loop Persistently Activates Platelet-Derived Growth Factor Receptor
H Lei, A Kazlauskas
Molecular and cellular biology 2013
EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180
H Feng, B Hu, K Vuori, JN Sarkaria, FB Furnari, WK Cavenee, SY Cheng
Oncogene 2013
Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
BS Paugh, X Zhu, C Qu, R Endersby, AK Diaz, J Zhang, DA Bax, D Carvalho, RM Reis, A Onar-Thomas, A Broniscer, C Wetmore, J Zhang, C Jones, DW Ellison, SJ Baker
Cancer research 2013
Heparan Sulfate Sulfatase SULF2 Regulates PDGFRα Signaling and Growth In Human and Mouse Malignant Glioma
Joanna Phillips, Emmanuelle Huillard, Aaron Robinson, Anna Ward, David Lum, Mei-Yin Polley, Steven Rosen, David Rowitch, Zena Werb
Journal of Clinical Investigation 2012
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
NJ Szerlip, A Pedraza, D Chakravarty, M Azim, J McGuire, Y Fang, T Ozawa, EC Holland, JT Huse, S Jhanwar, MA Leversha, T Mikkelsen, CW Brennan
Proceedings of the National Academy of Sciences 2012
Review: insights gained from modelling high-grade glioma in the mouse
SL Rankin, G Zhu, SJ Baker
Neuropathology and Applied Neurobiology 2012
Novel therapeutic targets in the brain tumor microenvironment.
Phillips JJ
Oncotarget 2012
Novel Therapeutic Targets in the Brain Tumor Microenvironment
Phillips JJ
Oncotarget 2012
Activation of Rac1 by Src-dependent Phosphorylation of Dock180Y1811 Mediates PDGFRα-stimulated Glioma Tumorigenesis in Mice and Humans
Haizhong Feng, Bo Hu, Kun-wei Liu, Yanxin Li, Xinghua Lu, Tao Cheng, Jia-Jean Yiin, Songjian Lu, Susan Keezer, Tim Fenton, Frank Furnari, Ronald Hamilton, Kristiina Vuori, Jann Sarkaria, Motoo Nagane, Ryo Nishikawa, Webster K. Cavenee, Shi-Yuan Cheng
Journal of Clinical Investigation 2011
Platelet-derived growth factor signaling in human malignancies
KW Liu, B Hu, SY Cheng
Chinese journal of cancer 2011
Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion
H Feng, KW Liu, P Guo, P Zhang, T Cheng, MA McNiven, GR Johnson, B Hu, SY Cheng
Oncogene 2011
Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell Lines
AR Hussain, S Uddin, R Bu, OS Khan, SO Ahmed, M Ahmed, KS Al-Kuraya
PloS one 2011
Platelet-derived growth factor receptor alpha in glioma: a bad seed
KW Liu, B Hu, SY Cheng
Chinese journal of cancer 2011
MicroRNAs as Regulators of Neural Stem Cell-Related Pathways in Glioblastoma Multiforme
P González-Gómez, P Sánchez, H Mira
Molecular Neurobiology 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
58 readers on Mendeley
See more details